Hormonal methods for emergency contraception

被引:0
|
作者
Li, Raymond Hang Wun [1 ,2 ]
Lo, Sue Seen Tsing [1 ,2 ]
Cameron, Sharon Tracey [3 ,4 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Sch Clin Med, Dept Obstet & Gynaecol,Pokfulam, 102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Family Planning Assoc Hong Kong, Wan Chai, 10th Floor,130 Hennessy Rd, Hong Kong, Peoples R China
[3] NHS Lothian, Chalmers Sexual Hlth Ctr, 2a Chalmers St, Edinburgh EH3 9ES, Scotland
[4] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh BioQuarter, Edinburgh EH16 4UU, Scotland
关键词
Hormonal emergency contraception; Levonorgestrel; Ulipristal acetate; Mifepristone; Cyclo-oxygenase inhibitors; HUMAN FALLOPIAN-TUBE; ULIPRISTAL ACETATE; IN-VITRO; YUZPE REGIMEN; ONLY PILL; LEVONORGESTREL; MIFEPRISTONE; PREGNANCY; WOMEN; ATTACHMENT;
D O I
10.1016/j.bpobgyn.2024.102550
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m2 or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNGreleasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Emergency hormonal contraception usage in genitourinary medicine clinic attenders
    Evans, JK
    Holmes, A
    Browning, M
    Forster, GE
    GENITOURINARY MEDICINE, 1996, 72 (03): : 217 - 219
  • [42] Strategies to improve adherence and acceptability of hormonal methods of contraception
    Halpern, Vera
    Lopez, Laureen M.
    Grimes, David A.
    Stockton, Laurie L.
    Gallo, Maria F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):
  • [43] Current hormonal Contraception Methods and the Risk of Breast Cancer
    Sauer, Georg
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (11) : 1066 - 1068
  • [44] Strategies to improve adherence and acceptability of hormonal methods for contraception
    Halpern, V
    Grimes, DA
    Lopez, L
    Gallo, MF
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [45] Strategies to improve adherence and acceptability of hormonal methods of contraception
    Halpern, Vera
    Lopez, Laureen M.
    Grimes, David A.
    Gallo, Maria F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04):
  • [46] Hormonal contraception and HIV: the methods have confused the message
    Schwartz, Sheree R.
    Pettifor, Audrey
    Stuart, Gretchen S.
    Cohen, Myron S.
    AIDS, 2013, 27 : S45 - S53
  • [47] Emergency Contraception: Current Methods, Usages and Issues
    Misro, Man M.
    Chaki, Sankar P.
    CURRENT WOMENS HEALTH REVIEWS, 2006, 2 (01) : 33 - 39
  • [48] HORMONAL CONTRACEPTION
    DORFMAN, RI
    LIFE SCIENCES, 1974, 14 (05) : 827 - 835
  • [49] HORMONAL CONTRACEPTION
    VOKAER, R
    BAYOT, D
    BULLETIN DE LA SOCIETE DES SCIENCES MEDICALES DU GRAND-DUCHE DE LUXEMBOURG, 1970, 107 (02): : 263 - &
  • [50] HORMONAL CONTRACEPTION
    TORTUL, MF
    CATTANEO, A
    LACOUR, I
    BAUDET, JH
    GAZETTE MEDICALE, 1990, 97 (32): : 25 - 28